Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

November 5, 2020

ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, today announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM’s cloud-based IGX Platform to manage, organize, and analyze T cell sequencing data.

ENPICOM has additionally developed a number of customizations making sure that the platform’s functionality fits Neogene’s specific data handling workflow to help Neogene’s research team leverage the full potential of their immune repertoire data.

“We are extremely proud to add Neogene Therapeutics to our IGX Platform customer base. Their recent $110 million Series A shows how important this new type of immunotherapy has become in the last few years,” stated Jos Lunenberg, CEO of ENPICOM.

Dedicated to developing personalized neoantigen T cell receptor (TCR) therapies for cancer, Neogene Therapeutics extensively studies immune repertoires of cancer patients by high-throughput T cell sequencing in order to identify T cell receptor genes with therapeutic value. Personalized neo-antigen TCR therapy is a novel approach to cancer treatment, where a patient’s T cells are genetically engineered with neoantigen specific TCR genes to enable them to identify and destroy tumor cells.

Dr. Carsten Linnemann, CEO of Neogene Therapeutics, added: “ENPICOM and the Neogene team have been collaborating for several years on various projects. ENPICOM has always been a thoughtful and highly reliable partner. It is a pleasure to utilize their innovative and unique IGX Platform.”

Since immune repertoire sequencing implies the generation of large amounts of data, there is a need for specific expertise to efficiently manage and fully exploit the potential of the data collected. ENPICOM’s IGX Platform provides Neogene with an efficient solution to manage and annotate T cell sequencing data.

The IGX Platform comes with powerful data management features and an intuitive user interface out of the box. Its modular, flexible structure allows for further enhancements and customizations. The custom robust workflow of the IGX Platform uniquely positions it to support high-throughput studies required to power Neogene’s research in personalized T cell therapies.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy